BCLS Acquisition Corp.

BCLS Acquisition Corp. (Nasdaq: BLSA) is a blank-check company formed to pursue an acquisition in the life sciences and healthcare sector. Sponsored by BCLS Capital, the vehicle completed its initial public offering in 2021 and was active in its target-search phase at the time it filed a Form 10-Q with the SEC on May 12, 2022, under accession number 0001193125-22-148725. The SPAC's focus on life sciences reflects continued SPAC-market appetite for biotech, medtech, and healthcare services transactions during that cycle. For the complete filing history, deal timeline, and sponsor background on BLSA, sign up for full data access at SpacDesk.